pralala的个人主页 - 老虎社区

pralala

pralala

暂无个人介绍

IP属地：未知

2关注

26粉丝

0主题

0勋章

2021-11-20

Power

SPAC Altimeter Growth jumps after setting vote date for Grab deal

2021-11-17

$PharmaCyte Biotech, Inc.(PMCB)$wow

2021-11-11

$Altimeter Growth Corp.(AGC)$GRAB

2021-11-08

$Remark Media(MARK)$Metaverse leggooo!!

2021-10-18

Yi

Valneva SE surged over 30% in premarket trading

2021-09-23

$Clover Health Corp(CLOV)$🙏🏽

2021-09-13

Yo

IPO Update: Definitive Healthcare Aims For $350 Million IPO

2021-08-28

$Lucid Group Inc(LCID)$Below 20 is a buy ✌🏽

2021-08-25

$Beyondspring Inc(BYSI)$PT $95/ $100

2021-08-18

$Virpax Pharmaceuticals, Inc.(VRPX)$Take a chill pill at this stock.. just know when to run 🙏🏽

2021-08-16

$Clover Health Corp(CLOV)$$10 EOW god pls

2021-08-16

$Beyondspring Inc(BYSI)$This price is a steal when it comes to the following months

2021-08-16

$Clover Health Corp(CLOV)$Why oh why!

2021-08-16

$Beyondspring Inc(BYSI)$Cmon $25

2021-08-16

😬

China's new home prices growth slows in July

2021-08-13

💪🏾

Biden Economic Agenda Confronts Tripwires Everywhere in Congress

2021-08-13

$Clover Health Corp(CLOV)$We saw 10 but it was only for a short period.. wait, what’s 10 when this has to be 100

2021-08-12

$Beyondspring Inc(BYSI)$Why is a good company having such trouble?

2021-08-11

$Beyondspring Inc(BYSI)$Why doesn’t it move much in Premarket

2021-08-06

$Clover Health Corp(CLOV)$It’s been quite long since we saw $CLOV green pre, during and post-market 🍀

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"3573383772698946","uuid":"3573383772698946","gmtCreate":1610289749407,"gmtModify":1638422982889,"name":"pralala","pinyin":"pralala","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/a6018cc8ea8414980b33b04dfc9fc497","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":26,"headSize":2,"tweetSize":166,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":3,"name":"书生虎","nameTw":"書生虎","represent":"努力向上","factor":"发布10条非转发主帖,其中5条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.05.26","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"228c86a078844d74991fff2b7ab2428d-3","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资合伙人虎","description":"证券账户累计交易金额达到100万美元","bigImgUrl":"https://static.tigerbbs.com/fbeac6bb240db7da8b972e5183d050ba","smallImgUrl":"https://static.tigerbbs.com/436cdf80292b99f0a992e78750ac4e3a","grayImgUrl":"https://static.tigerbbs.com/506a259a7b456f037592c3b23c779599","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":"93.07%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"35ec162348d5460f88c959321e554969-3","templateUuid":"35ec162348d5460f88c959321e554969","name":"传说交易员","description":"证券或期货账户累计交易次数达到300次","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"93.88%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":6,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":872980835,"gmtCreate":1637391829678,"gmtModify":1637391829841,"author":{"id":"3573383772698946","authorId":"3573383772698946","name":"pralala","avatar":"https://static.tigerbbs.com/a6018cc8ea8414980b33b04dfc9fc497","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573383772698946","authorIdStr":"3573383772698946"},"themes":[],"htmlText":"Power","listText":"Power","text":"Power","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/872980835","repostId":"1143065747","repostType":2,"repost":{"id":"1143065747","kind":"news","pubTimestamp":1637383902,"share":"https://www.laohu8.com/m/news/1143065747?lang=&edition=full","pubTime":"2021-11-20 12:51","market":"us","language":"en","title":"SPAC Altimeter Growth jumps after setting vote date for Grab deal","url":"https://stock-news.laohu8.com/highlight/detail?id=1143065747","media":"Seeking Alpha","summary":"SPAC Altimeter Growth Corp.  rose 4.6% after it set a Nov. 30 date for holders to vote on its deal t","content":"<p><a href=\"https://laohu8.com/S/AGC\">SPAC Altimeter Growth Corp. </a> rose 4.6% after it set a Nov. 30 date for holders to vote on its deal to take Southeast Asia ride-hailing giant Grab public.</p>\n<p><img src=\"https://static.tigerbbs.com/459798d9c6d2d0c428941e1ee2937f4b\" tg-width=\"894\" tg-height=\"635\" width=\"100%\" height=\"auto\"></p>\n<p>Brad Gerstner's AGC announced that that the SEC declared effective the Form F-4 registration statement of Grab Holdings, according to a release.</p>\n<p>Grab is Southeast Asia's most valuable startup and is set to undergo a merger with Altimeter (AGC) at a valuation of $40B in the fourth quarter, pushed back after a delay.</p>\n<p>The deal is expected to be the largest-ever U.S. equity offering by a Southeast Asian company. A public debut from Grab will offer investors access to a regional consumer market of more than 655M people across countries including Indonesia, Thailand and Vietnam.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>SPAC Altimeter Growth jumps after setting vote date for Grab deal</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSPAC Altimeter Growth jumps after setting vote date for Grab deal\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-20 12:51 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3773032-spac-altimeter-growth-jumps-after-sending-vote-date-for-grab-deal><strong>Seeking Alpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>SPAC Altimeter Growth Corp.  rose 4.6% after it set a Nov. 30 date for holders to vote on its deal to take Southeast Asia ride-hailing giant Grab public.\n\nBrad Gerstner's AGC announced that that the ...</p>\n\n<a href=\"https://seekingalpha.com/news/3773032-spac-altimeter-growth-jumps-after-sending-vote-date-for-grab-deal\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://seekingalpha.com/news/3773032-spac-altimeter-growth-jumps-after-sending-vote-date-for-grab-deal","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1143065747","content_text":"SPAC Altimeter Growth Corp.  rose 4.6% after it set a Nov. 30 date for holders to vote on its deal to take Southeast Asia ride-hailing giant Grab public.\n\nBrad Gerstner's AGC announced that that the SEC declared effective the Form F-4 registration statement of Grab Holdings, according to a release.\nGrab is Southeast Asia's most valuable startup and is set to undergo a merger with Altimeter (AGC) at a valuation of $40B in the fourth quarter, pushed back after a delay.\nThe deal is expected to be the largest-ever U.S. equity offering by a Southeast Asian company. A public debut from Grab will offer investors access to a regional consumer market of more than 655M people across countries including Indonesia, Thailand and Vietnam.","news_type":1},"isVote":1,"tweetType":1,"viewCount":898,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":871588627,"gmtCreate":1637084183038,"gmtModify":1637084183550,"author":{"id":"3573383772698946","authorId":"3573383772698946","name":"pralala","avatar":"https://static.tigerbbs.com/a6018cc8ea8414980b33b04dfc9fc497","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573383772698946","authorIdStr":"3573383772698946"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/PMCB\">$PharmaCyte Biotech, Inc.(PMCB)$</a>wow","listText":"<a href=\"https://laohu8.com/S/PMCB\">$PharmaCyte Biotech, Inc.(PMCB)$</a>wow","text":"$PharmaCyte Biotech, Inc.(PMCB)$wow","images":[{"img":"https://static.tigerbbs.com/b22cd61e4aed6b36a6af8185ff4f9cbc","width":"1170","height":"2184"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/871588627","isVote":1,"tweetType":1,"viewCount":761,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":870056603,"gmtCreate":1636560728345,"gmtModify":1636560728515,"author":{"id":"3573383772698946","authorId":"3573383772698946","name":"pralala","avatar":"https://static.tigerbbs.com/a6018cc8ea8414980b33b04dfc9fc497","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573383772698946","authorIdStr":"3573383772698946"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/AGC\">$Altimeter Growth Corp.(AGC)$</a>GRAB&nbsp;","listText":"<a href=\"https://laohu8.com/S/AGC\">$Altimeter Growth Corp.(AGC)$</a>GRAB&nbsp;","text":"$Altimeter Growth Corp.(AGC)$GRAB","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/870056603","isVote":1,"tweetType":1,"viewCount":1253,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":844394623,"gmtCreate":1636386921515,"gmtModify":1636386925815,"author":{"id":"3573383772698946","authorId":"3573383772698946","name":"pralala","avatar":"https://static.tigerbbs.com/a6018cc8ea8414980b33b04dfc9fc497","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573383772698946","authorIdStr":"3573383772698946"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/MARK\">$Remark Media(MARK)$</a>Metaverse leggooo!!","listText":"<a href=\"https://laohu8.com/S/MARK\">$Remark Media(MARK)$</a>Metaverse leggooo!!","text":"$Remark Media(MARK)$Metaverse leggooo!!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/844394623","isVote":1,"tweetType":1,"viewCount":1174,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":850946134,"gmtCreate":1634548437346,"gmtModify":1634548534125,"author":{"id":"3573383772698946","authorId":"3573383772698946","name":"pralala","avatar":"https://static.tigerbbs.com/a6018cc8ea8414980b33b04dfc9fc497","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573383772698946","authorIdStr":"3573383772698946"},"themes":[],"htmlText":"Yi","listText":"Yi","text":"Yi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/850946134","repostId":"1158357604","repostType":4,"repost":{"id":"1158357604","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1634544827,"share":"https://www.laohu8.com/m/news/1158357604?lang=&edition=full","pubTime":"2021-10-18 16:13","market":"us","language":"en","title":"Valneva SE surged over 30% in premarket trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1158357604","media":"Tiger Newspress","summary":"(Oct 18) Valneva shares jumped 30% in Paris trading after saying its coronavirus vaccine candidate o","content":"<p>(Oct 18)&nbsp;Valneva shares jumped 30% in Paris trading after saying its coronavirus vaccine candidate outperformed AstraZeneca's in a Phase 3 study, which met both its co-primary endpoints. Valneva said its vaccine had a neutralizing antibody seroconversion rate above 95% and that it had a better tolerability profile.</p>\n<p><img src=\"https://static.tigerbbs.com/75a47283d41a17f67d8b8e370e3900b7\" tg-width=\"1046\" tg-height=\"564\" referrerpolicy=\"no-referrer\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Valneva SE surged over 30% in premarket trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nValneva SE surged over 30% in premarket trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-10-18 16:13</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>(Oct 18)&nbsp;Valneva shares jumped 30% in Paris trading after saying its coronavirus vaccine candidate outperformed AstraZeneca's in a Phase 3 study, which met both its co-primary endpoints. Valneva said its vaccine had a neutralizing antibody seroconversion rate above 95% and that it had a better tolerability profile.</p>\n<p><img src=\"https://static.tigerbbs.com/75a47283d41a17f67d8b8e370e3900b7\" tg-width=\"1046\" tg-height=\"564\" referrerpolicy=\"no-referrer\"></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1158357604","content_text":"(Oct 18) Valneva shares jumped 30% in Paris trading after saying its coronavirus vaccine candidate outperformed AstraZeneca's in a Phase 3 study, which met both its co-primary endpoints. Valneva said its vaccine had a neutralizing antibody seroconversion rate above 95% and that it had a better tolerability profile.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1123,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":863016492,"gmtCreate":1632330976616,"gmtModify":1632801160394,"author":{"id":"3573383772698946","authorId":"3573383772698946","name":"pralala","avatar":"https://static.tigerbbs.com/a6018cc8ea8414980b33b04dfc9fc497","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573383772698946","authorIdStr":"3573383772698946"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/CLOV\">$Clover Health Corp(CLOV)$</a>🙏🏽","listText":"<a href=\"https://laohu8.com/S/CLOV\">$Clover Health Corp(CLOV)$</a>🙏🏽","text":"$Clover Health Corp(CLOV)$🙏🏽","images":[{"img":"https://static.tigerbbs.com/47e7305d55ee3423718c865071fc4788","width":"828","height":"1792"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/863016492","isVote":1,"tweetType":1,"viewCount":288,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":888538071,"gmtCreate":1631505801393,"gmtModify":1631891282873,"author":{"id":"3573383772698946","authorId":"3573383772698946","name":"pralala","avatar":"https://static.tigerbbs.com/a6018cc8ea8414980b33b04dfc9fc497","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573383772698946","authorIdStr":"3573383772698946"},"themes":[],"htmlText":"Yo","listText":"Yo","text":"Yo","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/888538071","repostId":"1164912986","repostType":4,"repost":{"id":"1164912986","kind":"news","pubTimestamp":1631503324,"share":"https://www.laohu8.com/m/news/1164912986?lang=&edition=full","pubTime":"2021-09-13 11:22","market":"us","language":"en","title":"IPO Update: Definitive Healthcare Aims For $350 Million IPO","url":"https://stock-news.laohu8.com/highlight/detail?id=1164912986","media":"seekingalpha","summary":"Summary\n\nDefinitive Healthcare has filed proposed terms for a $350 million IPO.\nThe firm provides da","content":"<p><b>Summary</b></p>\n<ul>\n <li>Definitive Healthcare has filed proposed terms for a $350 million IPO.</li>\n <li>The firm provides data and insights on the U.S. healthcare delivery ecosystem.</li>\n <li>DH is growing quickly, and while the IPO isn't cheap, the firm has strong prospects for growth ahead of it.</li>\n</ul>\n<p><b>Quick Take</b></p>\n<p>Definitive Healthcare (DH) has filed to raise $350 million from the sale of its Class A common stock in an IPO, according to an amendedregistration statement.</p>\n<p>The company provides commercial intelligence on the healthcare delivery ecosystem.</p>\n<p>I favor the space that DH is operating in and believe the firm has room for significant growth ahead of it.</p>\n<p>While the IPO isn’t cheap, the firm’s prospects outweigh its price and the IPO is worth a close look.</p>\n<p><b>Company &amp; Technology</b></p>\n<p>Framingham, Massachusetts-based Definitive was founded to develop a SaaS platform to deliver data and insights into all aspects of the healthcare delivery system.</p>\n<p>Management is headed by founder, Chairman and CEO, Jason Krantz, who has been with the firm since inception and was previously CEO of Infinata, a SaaS provider of intelligence to the pharmaceutical industry.</p>\n<p>The company’s primary offerings by client use case include:</p>\n<ul>\n <li><p>Sales</p></li>\n <li><p>Marketing</p></li>\n <li><p>Clinical research &amp; product development</p></li>\n <li><p>Strategy</p></li>\n <li><p>Talent acquisition</p></li>\n <li><p>Physician network management</p></li>\n</ul>\n<p>Definitive has received at least $1.3 billion in equity investment from investors including Advent International, Spectrum Equity, DH Holdings, AIDH Management Holdings, and 22C Capital.</p>\n<p><b>Customer Acquisition</b></p>\n<p>The firm seeks customer relationships with:</p>\n<ul>\n <li><p>Life science companies</p></li>\n <li><p>Healthcare IT companies</p></li>\n <li><p>Healthcare providers</p></li>\n <li><p>Staffing firms</p></li>\n <li><p>Real estate firms</p></li>\n</ul>\n<p>The company counts over 2,600 companies as customers as of June 30, 2021, with no single customer accounting for more than 2% of its revenue.</p>\n<p>Sales and Marketing expenses as a percentage of total revenue have fluctuated as revenues have increased, as the figures below indicate:</p>\n<p><img src=\"https://static.tigerbbs.com/026b2d77e244b1f55f93aa472f21b1cf\" tg-width=\"608\" tg-height=\"302\" referrerpolicy=\"no-referrer\"></p>\n<p>The Sales and Marketing efficiency rate, defined as how many dollars of additional new revenue are generated by each dollar of Sales and Marketing spend, fell slightly to 0.9x in the most recent reporting period, as shown in the table below:</p>\n<p><img src=\"https://static.tigerbbs.com/c9d709fbb5e028251cc9cd4336f21056\" tg-width=\"611\" tg-height=\"243\" referrerpolicy=\"no-referrer\">The Rule of 40 is a software industry rule of thumb that says that as long as the combined revenue growth rate and EBITDA percentage rate equal or exceed 40%, the firm is on an acceptable growth/EBITDA trajectory.</p>\n<p>DH’s most recent calculation was 29% as of June 30, 2021, so the firm has some room for improvement in this regard, per the table below:</p>\n<p><img src=\"https://static.tigerbbs.com/8ddc5db6ab674c100956364525454370\" tg-width=\"610\" tg-height=\"243\" referrerpolicy=\"no-referrer\">The firm’s dollar-based net revenue retention rate for the year ended June 30, 2021 was 111%, a good result.</p>\n<p>The dollar-based net revenue retention rate metric measures how much additional revenue is generated over time from each cohort of customers, so that a figure over 100% means that the company is generating more revenue from the same customer cohort over time, indicating good product/market fit and efficient sales and marketing efforts.</p>\n<p><b>Market &amp; Competition</b></p>\n<p>According to a 2019 marketresearch reportby Grand View Research, the global market for healthcare analytics was an estimated $25.9 billion in 2019 and is expected to reach $46 billion by 2027.</p>\n<p>This represents a forecast CAGR of 7.5% from 2020 to 2027.</p>\n<p>The main drivers for this expected growth are continued digitization of healthcare data, technological advancements, and pressure to reduce healthcare spending through efficiencies.</p>\n<p>Also, the COVID-19 pandemic has provided a boost to these trends and will likely pull forward demand from healthcare ecosystem companies for greater information and capabilities.</p>\n<p>Major competitive or other industry participants include:</p>\n<ul>\n <li><p>Clarivate(NYSE:CLVT)</p></li>\n <li><p>IQVIA(NYSE:IQV)</p></li>\n <li><p>Symphony Health</p></li>\n <li><p>Komodo Health</p></li>\n <li><p>H1 Healthcare</p></li>\n <li><p>Marketware</p></li>\n <li><p>Trella Health</p></li>\n <li><p>Trilliant Health</p></li>\n <li><p>SG2</p></li>\n <li><p>Veeva(NYSE:VEEV)</p></li>\n <li><p>Others</p></li>\n</ul>\n<p><b>Financial Performance</b></p>\n<p>Definitive’s recent financial results can be summarized as follows:</p>\n<ul>\n <li><p>Growing top line revenue</p></li>\n <li><p>Increasing gross profit and high gross margin</p></li>\n <li><p>Lowered operating losses and reduced negative operating margin</p></li>\n <li><p>Increasing cash flow from operations</p></li>\n</ul>\n<p>Below are relevant financial results derived from the firm’s registration statement:</p>\n<p><img src=\"https://static.tigerbbs.com/f71dd7e0d03f204839bbae185b0b4c54\" tg-width=\"609\" tg-height=\"618\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/5a22d972f93023350902eb166b3f6338\" tg-width=\"611\" tg-height=\"619\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/81392f625bdb5fcfddccf32a18235cca\" tg-width=\"610\" tg-height=\"618\" referrerpolicy=\"no-referrer\">As of June 30, 2021, Definitive had $38 million in cash and $555 million in total liabilities.</p>\n<p>Free cash flow during the twelve months ended June 30, 2021 was $25.7 million.</p>\n<p><b>IPO Details</b></p>\n<p>DH intends to sell 15.55 million shares of Class A at a proposed midpoint price of $22.50 per share for gross proceeds of approximately $350 million, not including the sale of customary underwriter options.</p>\n<p>BlackRock and Capital World have indicated a non-binding interest to purchase shares of up to an aggregate of $80 million at the IPO price.</p>\n<p>Class A and Class B common stockholders will each have one vote, but Class B stockholders will not have economic rights.</p>\n<p>The S&amp;P 500 Index no longer admits firms with multiple classes of stock into its index.</p>\n<p>Assuming a successful IPO at the midpoint of the proposed price range, the company’s enterprise value at IPO (ex-underwriter options) would approximate $4.8 billion.</p>\n<p>Excluding effects of underwriter options and private placement shares or restricted stock, if any, the float to outstanding shares ratio will be approximately 7.48%. A figure under 10% is generally considered a ‘low float’ stock which can be subject to significant price volatility.</p>\n<p>Per the firm’s most recent regulatory filing, it plans to use the net proceeds as follows:</p>\n<blockquote>\n We intend to use a portion of the net proceeds from this offering to [i] purchase 14,222,222 newly issued LLC Units (or 14,222,222 LLC Units, if the underwriters exercise their over-allotment option to purchase additional shares of Class A common stock in full) from Definitive OpCo, [ii] acquire 425,229 LLC Units from Pre-IPO LLC Members, and [iii] repurchase 908,104 shares of Class A common stock received by the Blocker Company equityholders in connection with the Mergers. The foregoing purchases of LLC Units and Class A common stock, respectively, will be at a price per unit equal to the public offering price per share of Class A common stock in this offering, less the underwriting discount. We have agreed to reimburse approximately $1.05 million in aggregate expenses incurred by our Sponsors in connection with the Reorganization Transactions. See “Organizational Structure—The Reorganization Transactions.”\n</blockquote>\n<blockquote>\n We will cause Definitive OpCo to use the proceeds from the issuance of the LLC Units to Definitive Healthcare Corp. as follows: [i] to pay fees and expenses not already paid from our total estimate of approximately $10.1 million in connection with this offering and the Reorganization Transactions; [ii] to repay $195.4 million of the outstanding borrowings under our Senior Credit Facilities and [iii] for general corporate purposes. Definitive OpCo will not receive any proceeds from the purchase of LLC Units from certain Pre-IPO LLC Members by us or from the repurchase of shares of Class A common stock by us.\n</blockquote>\n<p>Management’s presentation of the company roadshow isavailable here.</p>\n<p>Regarding outstanding legal proceedings, no matters are judged by management to have the potential for a material impact on the firm's operations or financial condition.</p>\n<p>Listed underwriters of the IPO are Goldman Sachs, J.P. Morgan, and several other investment banks.</p>\n<p><b>Valuation Metrics</b></p>\n<p>Below is a table of the firm’s relevant capitalization and valuation metrics at IPO, excluding the effects of underwriter options:</p>\n<p><img src=\"https://static.tigerbbs.com/0b571173d651609bed2288d8f2bb996b\" tg-width=\"614\" tg-height=\"706\" referrerpolicy=\"no-referrer\">As a reference, a potential public comparable would be Veeva Systems, although Veeva is a much larger company; shown below is a comparison of their primary valuation metrics:</p>\n<p><img src=\"https://static.tigerbbs.com/c402e45b255ff93386bdb1666f2f2740\" tg-width=\"610\" tg-height=\"360\" referrerpolicy=\"no-referrer\">Commentary</p>\n<p>DH seeks to go public to pay down debt and purchase underlying LLC interests.</p>\n<p>The firm’s financials show strong top line revenue growth and gross profit results, continued operating losses but reduced negative operating margin, so the firm appears to be making progress in this regard.</p>\n<p>Cash flow from operations is growing quickly and free cash flow for the twelve months ended June 30, 2021, was a solid $25.7 million.</p>\n<p>Sales and Marketing expenses as a percentage of total revenue have fluctuated as revenue has increased; its Sales and Marketing efficiency rate dropped slightly in the most recent reporting period.</p>\n<p>The company’s dollar-based net retention rate of 111% is a good performance metric that shows good product market fit and efficient sales &amp; marketing efforts.</p>\n<p>The market opportunity for providing healthcare delivery industry data to a wide variety of market participants is large and expected to grow at a moderate rate of growth over the coming years.</p>\n<p>Goldman Sachs is one of the lead underwriters and IPOs led by the firm over the last 12-month period have generated an average return of 45.1% since their IPO. This is a mid-tier performance for all major underwriters during the period.</p>\n<p>The primary risk to the company’s outlook is the increasing competitiveness in the markets in which it operates which may produce downward pressure on the firm’s pricing power over time.</p>\n<p>As for valuation, DH is within range of much larger competitor Veeva on revenue multiples, with a slight premium as DH is growing revenue at a faster rate of growth.</p>\n<p>However, on an EV/EBITDA or earnings basis, the DH IPO is far higher valued than Veeva’s current stock price.</p>\n<p>Still, I like the space that DH is operating in and believe the company has room for significant growth ahead of it.</p>\n<p>While the IPO isn’t cheap, the firm’s prospects outweigh its price and the IPO is worth consideration.</p>\n<p>Expected IPO Pricing Date: September 14, 2021.</p>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>IPO Update: Definitive Healthcare Aims For $350 Million IPO</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIPO Update: Definitive Healthcare Aims For $350 Million IPO\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-13 11:22 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/article/4454054-ipo-update-definitive-healthcare-aims-for-350-million-ipo><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Summary\n\nDefinitive Healthcare has filed proposed terms for a $350 million IPO.\nThe firm provides data and insights on the U.S. healthcare delivery ecosystem.\nDH is growing quickly, and while the IPO ...</p>\n\n<a href=\"https://seekingalpha.com/article/4454054-ipo-update-definitive-healthcare-aims-for-350-million-ipo\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"DH":"Definitive Healthcare Corp."},"source_url":"https://seekingalpha.com/article/4454054-ipo-update-definitive-healthcare-aims-for-350-million-ipo","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"1164912986","content_text":"Summary\n\nDefinitive Healthcare has filed proposed terms for a $350 million IPO.\nThe firm provides data and insights on the U.S. healthcare delivery ecosystem.\nDH is growing quickly, and while the IPO isn't cheap, the firm has strong prospects for growth ahead of it.\n\nQuick Take\nDefinitive Healthcare (DH) has filed to raise $350 million from the sale of its Class A common stock in an IPO, according to an amendedregistration statement.\nThe company provides commercial intelligence on the healthcare delivery ecosystem.\nI favor the space that DH is operating in and believe the firm has room for significant growth ahead of it.\nWhile the IPO isn’t cheap, the firm’s prospects outweigh its price and the IPO is worth a close look.\nCompany & Technology\nFramingham, Massachusetts-based Definitive was founded to develop a SaaS platform to deliver data and insights into all aspects of the healthcare delivery system.\nManagement is headed by founder, Chairman and CEO, Jason Krantz, who has been with the firm since inception and was previously CEO of Infinata, a SaaS provider of intelligence to the pharmaceutical industry.\nThe company’s primary offerings by client use case include:\n\nSales\nMarketing\nClinical research & product development\nStrategy\nTalent acquisition\nPhysician network management\n\nDefinitive has received at least $1.3 billion in equity investment from investors including Advent International, Spectrum Equity, DH Holdings, AIDH Management Holdings, and 22C Capital.\nCustomer Acquisition\nThe firm seeks customer relationships with:\n\nLife science companies\nHealthcare IT companies\nHealthcare providers\nStaffing firms\nReal estate firms\n\nThe company counts over 2,600 companies as customers as of June 30, 2021, with no single customer accounting for more than 2% of its revenue.\nSales and Marketing expenses as a percentage of total revenue have fluctuated as revenues have increased, as the figures below indicate:\n\nThe Sales and Marketing efficiency rate, defined as how many dollars of additional new revenue are generated by each dollar of Sales and Marketing spend, fell slightly to 0.9x in the most recent reporting period, as shown in the table below:\nThe Rule of 40 is a software industry rule of thumb that says that as long as the combined revenue growth rate and EBITDA percentage rate equal or exceed 40%, the firm is on an acceptable growth/EBITDA trajectory.\nDH’s most recent calculation was 29% as of June 30, 2021, so the firm has some room for improvement in this regard, per the table below:\nThe firm’s dollar-based net revenue retention rate for the year ended June 30, 2021 was 111%, a good result.\nThe dollar-based net revenue retention rate metric measures how much additional revenue is generated over time from each cohort of customers, so that a figure over 100% means that the company is generating more revenue from the same customer cohort over time, indicating good product/market fit and efficient sales and marketing efforts.\nMarket & Competition\nAccording to a 2019 marketresearch reportby Grand View Research, the global market for healthcare analytics was an estimated $25.9 billion in 2019 and is expected to reach $46 billion by 2027.\nThis represents a forecast CAGR of 7.5% from 2020 to 2027.\nThe main drivers for this expected growth are continued digitization of healthcare data, technological advancements, and pressure to reduce healthcare spending through efficiencies.\nAlso, the COVID-19 pandemic has provided a boost to these trends and will likely pull forward demand from healthcare ecosystem companies for greater information and capabilities.\nMajor competitive or other industry participants include:\n\nClarivate(NYSE:CLVT)\nIQVIA(NYSE:IQV)\nSymphony Health\nKomodo Health\nH1 Healthcare\nMarketware\nTrella Health\nTrilliant Health\nSG2\nVeeva(NYSE:VEEV)\nOthers\n\nFinancial Performance\nDefinitive’s recent financial results can be summarized as follows:\n\nGrowing top line revenue\nIncreasing gross profit and high gross margin\nLowered operating losses and reduced negative operating margin\nIncreasing cash flow from operations\n\nBelow are relevant financial results derived from the firm’s registration statement:\nAs of June 30, 2021, Definitive had $38 million in cash and $555 million in total liabilities.\nFree cash flow during the twelve months ended June 30, 2021 was $25.7 million.\nIPO Details\nDH intends to sell 15.55 million shares of Class A at a proposed midpoint price of $22.50 per share for gross proceeds of approximately $350 million, not including the sale of customary underwriter options.\nBlackRock and Capital World have indicated a non-binding interest to purchase shares of up to an aggregate of $80 million at the IPO price.\nClass A and Class B common stockholders will each have one vote, but Class B stockholders will not have economic rights.\nThe S&P 500 Index no longer admits firms with multiple classes of stock into its index.\nAssuming a successful IPO at the midpoint of the proposed price range, the company’s enterprise value at IPO (ex-underwriter options) would approximate $4.8 billion.\nExcluding effects of underwriter options and private placement shares or restricted stock, if any, the float to outstanding shares ratio will be approximately 7.48%. A figure under 10% is generally considered a ‘low float’ stock which can be subject to significant price volatility.\nPer the firm’s most recent regulatory filing, it plans to use the net proceeds as follows:\n\n We intend to use a portion of the net proceeds from this offering to [i] purchase 14,222,222 newly issued LLC Units (or 14,222,222 LLC Units, if the underwriters exercise their over-allotment option to purchase additional shares of Class A common stock in full) from Definitive OpCo, [ii] acquire 425,229 LLC Units from Pre-IPO LLC Members, and [iii] repurchase 908,104 shares of Class A common stock received by the Blocker Company equityholders in connection with the Mergers. The foregoing purchases of LLC Units and Class A common stock, respectively, will be at a price per unit equal to the public offering price per share of Class A common stock in this offering, less the underwriting discount. We have agreed to reimburse approximately $1.05 million in aggregate expenses incurred by our Sponsors in connection with the Reorganization Transactions. See “Organizational Structure—The Reorganization Transactions.”\n\n\n We will cause Definitive OpCo to use the proceeds from the issuance of the LLC Units to Definitive Healthcare Corp. as follows: [i] to pay fees and expenses not already paid from our total estimate of approximately $10.1 million in connection with this offering and the Reorganization Transactions; [ii] to repay $195.4 million of the outstanding borrowings under our Senior Credit Facilities and [iii] for general corporate purposes. Definitive OpCo will not receive any proceeds from the purchase of LLC Units from certain Pre-IPO LLC Members by us or from the repurchase of shares of Class A common stock by us.\n\nManagement’s presentation of the company roadshow isavailable here.\nRegarding outstanding legal proceedings, no matters are judged by management to have the potential for a material impact on the firm's operations or financial condition.\nListed underwriters of the IPO are Goldman Sachs, J.P. Morgan, and several other investment banks.\nValuation Metrics\nBelow is a table of the firm’s relevant capitalization and valuation metrics at IPO, excluding the effects of underwriter options:\nAs a reference, a potential public comparable would be Veeva Systems, although Veeva is a much larger company; shown below is a comparison of their primary valuation metrics:\nCommentary\nDH seeks to go public to pay down debt and purchase underlying LLC interests.\nThe firm’s financials show strong top line revenue growth and gross profit results, continued operating losses but reduced negative operating margin, so the firm appears to be making progress in this regard.\nCash flow from operations is growing quickly and free cash flow for the twelve months ended June 30, 2021, was a solid $25.7 million.\nSales and Marketing expenses as a percentage of total revenue have fluctuated as revenue has increased; its Sales and Marketing efficiency rate dropped slightly in the most recent reporting period.\nThe company’s dollar-based net retention rate of 111% is a good performance metric that shows good product market fit and efficient sales & marketing efforts.\nThe market opportunity for providing healthcare delivery industry data to a wide variety of market participants is large and expected to grow at a moderate rate of growth over the coming years.\nGoldman Sachs is one of the lead underwriters and IPOs led by the firm over the last 12-month period have generated an average return of 45.1% since their IPO. This is a mid-tier performance for all major underwriters during the period.\nThe primary risk to the company’s outlook is the increasing competitiveness in the markets in which it operates which may produce downward pressure on the firm’s pricing power over time.\nAs for valuation, DH is within range of much larger competitor Veeva on revenue multiples, with a slight premium as DH is growing revenue at a faster rate of growth.\nHowever, on an EV/EBITDA or earnings basis, the DH IPO is far higher valued than Veeva’s current stock price.\nStill, I like the space that DH is operating in and believe the company has room for significant growth ahead of it.\nWhile the IPO isn’t cheap, the firm’s prospects outweigh its price and the IPO is worth consideration.\nExpected IPO Pricing Date: September 14, 2021.","news_type":1},"isVote":1,"tweetType":1,"viewCount":446,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":819466468,"gmtCreate":1630092742054,"gmtModify":1704955846982,"author":{"id":"3573383772698946","authorId":"3573383772698946","name":"pralala","avatar":"https://static.tigerbbs.com/a6018cc8ea8414980b33b04dfc9fc497","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573383772698946","authorIdStr":"3573383772698946"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/LCID\">$Lucid Group Inc(LCID)$</a>Below 20 is a buy ✌🏽","listText":"<a href=\"https://laohu8.com/S/LCID\">$Lucid Group Inc(LCID)$</a>Below 20 is a buy ✌🏽","text":"$Lucid Group Inc(LCID)$Below 20 is a buy ✌🏽","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/819466468","isVote":1,"tweetType":1,"viewCount":563,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":837263172,"gmtCreate":1629894258796,"gmtModify":1631888785676,"author":{"id":"3573383772698946","authorId":"3573383772698946","name":"pralala","avatar":"https://static.tigerbbs.com/a6018cc8ea8414980b33b04dfc9fc497","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573383772698946","authorIdStr":"3573383772698946"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/BYSI\">$Beyondspring Inc(BYSI)$</a>PT $95/&nbsp;$100","listText":"<a href=\"https://laohu8.com/S/BYSI\">$Beyondspring Inc(BYSI)$</a>PT $95/&nbsp;$100","text":"$Beyondspring Inc(BYSI)$PT $95/ $100","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/837263172","isVote":1,"tweetType":1,"viewCount":528,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":831355541,"gmtCreate":1629291502783,"gmtModify":1631888957185,"author":{"id":"3573383772698946","authorId":"3573383772698946","name":"pralala","avatar":"https://static.tigerbbs.com/a6018cc8ea8414980b33b04dfc9fc497","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573383772698946","authorIdStr":"3573383772698946"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/VRPX\">$Virpax Pharmaceuticals, Inc.(VRPX)$</a>Take a chill&nbsp;pill at this stock.. just know when to run 🙏🏽","listText":"<a href=\"https://laohu8.com/S/VRPX\">$Virpax Pharmaceuticals, Inc.(VRPX)$</a>Take a chill&nbsp;pill at this stock.. just know when to run 🙏🏽","text":"$Virpax Pharmaceuticals, Inc.(VRPX)$Take a chill pill at this stock.. just know when to run 🙏🏽","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/831355541","isVote":1,"tweetType":1,"viewCount":388,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":839377380,"gmtCreate":1629124506940,"gmtModify":1631885122572,"author":{"id":"3573383772698946","authorId":"3573383772698946","name":"pralala","avatar":"https://static.tigerbbs.com/a6018cc8ea8414980b33b04dfc9fc497","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573383772698946","authorIdStr":"3573383772698946"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/CLOV\">$Clover Health Corp(CLOV)$</a>$10 EOW god pls","listText":"<a href=\"https://laohu8.com/S/CLOV\">$Clover Health Corp(CLOV)$</a>$10 EOW god pls","text":"$Clover Health Corp(CLOV)$$10 EOW god pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/839377380","isVote":1,"tweetType":1,"viewCount":118,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":839319439,"gmtCreate":1629121941021,"gmtModify":1631888785680,"author":{"id":"3573383772698946","authorId":"3573383772698946","name":"pralala","avatar":"https://static.tigerbbs.com/a6018cc8ea8414980b33b04dfc9fc497","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573383772698946","authorIdStr":"3573383772698946"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/BYSI\">$Beyondspring Inc(BYSI)$</a>This price is a steal when it comes to the following months&nbsp;","listText":"<a href=\"https://laohu8.com/S/BYSI\">$Beyondspring Inc(BYSI)$</a>This price is a steal when it comes to the following months&nbsp;","text":"$Beyondspring Inc(BYSI)$This price is a steal when it comes to the following months","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/839319439","isVote":1,"tweetType":1,"viewCount":264,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":839936799,"gmtCreate":1629114735211,"gmtModify":1631885122590,"author":{"id":"3573383772698946","authorId":"3573383772698946","name":"pralala","avatar":"https://static.tigerbbs.com/a6018cc8ea8414980b33b04dfc9fc497","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573383772698946","authorIdStr":"3573383772698946"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/CLOV\">$Clover Health Corp(CLOV)$</a>Why oh why!","listText":"<a href=\"https://laohu8.com/S/CLOV\">$Clover Health Corp(CLOV)$</a>Why oh why!","text":"$Clover Health Corp(CLOV)$Why oh why!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/839936799","isVote":1,"tweetType":1,"viewCount":247,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":830747541,"gmtCreate":1629103018083,"gmtModify":1631888785684,"author":{"id":"3573383772698946","authorId":"3573383772698946","name":"pralala","avatar":"https://static.tigerbbs.com/a6018cc8ea8414980b33b04dfc9fc497","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573383772698946","authorIdStr":"3573383772698946"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/BYSI\">$Beyondspring Inc(BYSI)$</a>Cmon $25&nbsp;","listText":"<a href=\"https://laohu8.com/S/BYSI\">$Beyondspring Inc(BYSI)$</a>Cmon $25&nbsp;","text":"$Beyondspring Inc(BYSI)$Cmon $25","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/830747541","isVote":1,"tweetType":1,"viewCount":220,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":830508508,"gmtCreate":1629079084804,"gmtModify":1631891282877,"author":{"id":"3573383772698946","authorId":"3573383772698946","name":"pralala","avatar":"https://static.tigerbbs.com/a6018cc8ea8414980b33b04dfc9fc497","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573383772698946","authorIdStr":"3573383772698946"},"themes":[],"htmlText":"😬","listText":"😬","text":"😬","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/830508508","repostId":"2159906245","repostType":4,"repost":{"id":"2159906245","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1629077911,"share":"https://www.laohu8.com/m/news/2159906245?lang=&edition=full","pubTime":"2021-08-16 09:38","market":"sh","language":"en","title":"China's new home prices growth slows in July","url":"https://stock-news.laohu8.com/highlight/detail?id=2159906245","media":"Reuters","summary":"BEIJING, Aug 16 (Reuters) - China's new home prices in July rose at the slowest pace since January, ","content":"<p>BEIJING, Aug 16 (Reuters) - China's new home prices in July rose at the slowest pace since January, official data showed on Monday, after authorities further tightened curbs on the sector, including limits on some purchases.</p>\n<p>Average new home prices in 70 major cities grew 0.3% in July from a month earlier, slowing from a 0.5% rise in June, according to Reuters calculations based on data released by the National Bureau of Statistics.</p>\n<p>On annual basis, new home prices rose 4.6%, compared with a 4.7% uptick in June.</p>\n<p>China's property market has rebounded quickly from the COVID-19 crisis, triggering concerns about financial risks in an overheated market. This year authorities stepped up curbs on the sector to rein in runaway housing prices.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>China's new home prices growth slows in July</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChina's new home prices growth slows in July\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-08-16 09:38</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>BEIJING, Aug 16 (Reuters) - China's new home prices in July rose at the slowest pace since January, official data showed on Monday, after authorities further tightened curbs on the sector, including limits on some purchases.</p>\n<p>Average new home prices in 70 major cities grew 0.3% in July from a month earlier, slowing from a 0.5% rise in June, according to Reuters calculations based on data released by the National Bureau of Statistics.</p>\n<p>On annual basis, new home prices rose 4.6%, compared with a 4.7% uptick in June.</p>\n<p>China's property market has rebounded quickly from the COVID-19 crisis, triggering concerns about financial risks in an overheated market. This year authorities stepped up curbs on the sector to rein in runaway housing prices.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"399001":"深证成指","399006":"创业板指","000001.SH":"上证指数"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2159906245","content_text":"BEIJING, Aug 16 (Reuters) - China's new home prices in July rose at the slowest pace since January, official data showed on Monday, after authorities further tightened curbs on the sector, including limits on some purchases.\nAverage new home prices in 70 major cities grew 0.3% in July from a month earlier, slowing from a 0.5% rise in June, according to Reuters calculations based on data released by the National Bureau of Statistics.\nOn annual basis, new home prices rose 4.6%, compared with a 4.7% uptick in June.\nChina's property market has rebounded quickly from the COVID-19 crisis, triggering concerns about financial risks in an overheated market. This year authorities stepped up curbs on the sector to rein in runaway housing prices.","news_type":1},"isVote":1,"tweetType":1,"viewCount":211,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":894822430,"gmtCreate":1628817541220,"gmtModify":1631891282879,"author":{"id":"3573383772698946","authorId":"3573383772698946","name":"pralala","avatar":"https://static.tigerbbs.com/a6018cc8ea8414980b33b04dfc9fc497","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573383772698946","authorIdStr":"3573383772698946"},"themes":[],"htmlText":"💪🏾","listText":"💪🏾","text":"💪🏾","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/894822430","repostId":"1154636497","repostType":4,"repost":{"id":"1154636497","kind":"news","pubTimestamp":1628816538,"share":"https://www.laohu8.com/m/news/1154636497?lang=&edition=full","pubTime":"2021-08-13 09:02","market":"hk","language":"en","title":"Biden Economic Agenda Confronts Tripwires Everywhere in Congress","url":"https://stock-news.laohu8.com/highlight/detail?id=1154636497","media":"Bloomberg","summary":"Debt ceiling, funding deadline complicates path after break\nDemocrats aim for early fall completion,","content":"<ul>\n <li>Debt ceiling, funding deadline complicates path after break</li>\n <li>Democrats aim for early fall completion, but obstacles await</li>\n</ul>\n<p>The central pieces of President Joe Biden’s $4.1 trillion economic agenda are now moving through Congress on a precarious two-track path that’s further complicated by a September showdown over the debt ceiling.</p>\n<p>Funding for the government will expire and the Treasury will approach the limit of its borrowing authority just as congressional Democrats try to make the administration’s massive infrastructure and social spending plans a reality.</p>\n<p>The convergence will test the limits of how well House Speaker Nancy Pelosi and Senator Majority Leader Chuck Schumer can manage their narrow -- and often fractious -- majorities and Biden’s ability to bargain with dissenters.</p>\n<p>The first part of Biden’s plan, infrastructure legislation with $550 billion in new spending, passed the Senate on a bipartisan basis. But the framework for a much larger plan -- a $3.5 trillion budget resolution opening the way to expansive spending on social programs paid for in part by taxes on the wealthy and corporations -- squeaked through on a straight party-line vote.</p>\n<p>Here’s what’s ahead for a process that could last through year-end:</p>\n<p>House Vote</p>\n<p>Pelosi is briefly interrupting the chamber’s summer recess by calling lawmakers back to <a href=\"https://laohu8.com/S/WASH\">Washington</a> on Aug. 23 to vote on the Senate’s budget resolution.</p>\n<p>She needs near-unanimous Democratic support to adopt it against anticipated unified GOP opposition. The resolution is just an outline setting the parameters for an eventual budget bill and instructions for committees to draw up legislative text. It doesn’t require the president’s signature.</p>\n<p>For now, the infrastructure bill is on hold. In a bow to demands by House progressives, Pelosi has vowed to wait until the Senate finishes the budget package to assure it addresses priorities on social programs and climate change. House Democrats may also want changes to the carefully negotiated infrastructure legislation.</p>\n<p>Committee Work</p>\n<p>Both chambers will then move to write precise policies and other language for the massive budget package, with the House likely to go first, predicts Zach Moller, a former Democratic Senate staffer who now works for Third Way, a centrist policy-research organization.</p>\n<p>House Democrats, ranging from top Pelosi lieutenants and powerful committee chairs to upstart progressives, are already signaling various changes they want to see in a final version of the Senate’s reconciliation package.</p>\n<p>The Senate-passed resolution sets a nonbinding Sept. 15 deadline for committees in both chambers to submit proposals to their respective budget panels.</p>\n<p>The Senate Finance Committee has jurisdiction over the heart of the package, including the tax hikes on the wealthy and corporations. Other committees can increase the deficit by about $1.75 trillion combined over a decade -- meaningup tohalf of Biden’s plan could be debt-financed.</p>\n<p>There is no firm deadline on passage of the economic agenda, but Democrats keen on keeping their congressional majorities in the November 2022 midterm elections want the packages enacted this fall. That would allow voters time tofeelthe legislation’s effects and provide for the extension of popular pandemic-era benefits like the expanded child tax credit, which would otherwise end in December.</p>\n<p>Funding Showdown</p>\n<p>By Sept. 30, lawmakers must reach bipartisan deals on unfinished regular government spending bills or on a stopgap bill to keep agencies running that would maintain current spending levels through at least October or early November.</p>\n<p>Such a measure could carry language temporarily suspending the debt limit. But doing so could trigger a government shutdown. Republicans say Democrats must go it alone on the debt ceiling and want them to revise the budget resolution to allow them to pass a hike with a simple majority.</p>\n<p>Senate Democrats, however, insist for now on using the regular legislative process, which would require at least 10 Republicans to join them. Prospects for a bitter battle this fall have alreadystarted to impact short-term debt markets.</p>\n<p>Hazards Ahead</p>\n<p>Obstacles abound in the coming months. For <a href=\"https://laohu8.com/S/AONE.U\">one</a>, House Democrats can afford just three defectors in a party-line vote. In the evenly divided Senate, unity is the only option.</p>\n<p>Even the House’s vote this month on the budget framework is no slam dunk. Party moderates, who want an immediate vote on the infrastructure package, could withhold their backing, stalling the measure.</p>\n<p>In the Senate, not all Democrats are on board with the $3.5 trillion package, even though they all voted for the framework. Some, like Kyrsten Sinema of Arizona and Joe Manchin of <a href=\"https://laohu8.com/S/WSTC\">West</a> Virginia, say they’re uncomfortable with the price tag or the size of the tax hikes Biden has proposed to help pay for it.</p>\n<p>Manchin has also said he disagrees with Democrats who want to target fossil fuels -- setting up tension for a key piece of the legislation.</p>\n<p>Schumer asserted Wednesday Democrats would ultimately unite, but he acknowledged it wouldn’t be easy.</p>\n<p>Republicans will have ample opportunity to split Democrats and make their case that more taxes and spending will increase inflation and hurt the economy. Under special Senate rules they can force nearly unlimited amendments trying to strike individual provisions, potentially peeling off some Democrats in politically fraught votes.</p>\n<p>Procedural Pitfalls</p>\n<p>The package will still have to clear a major procedural hurdle scrubbing it of anything deemed incidental to the federal budget.</p>\n<p>Biden’s $1.9 trillion Covid-19 relief package was shorn of a proposal for a $15-an-hour minimum wage via that process. Potential challenges in the $3.5 trillion plan include providing a path to citizenship for millions of immigrants.</p>\n<p>All of this comes with long-term implications. In the short term, any misstep -- particularly on government spending and the debt ceiling -- could have large-scale reverberations in the market and the broader economy.</p>\n<p>“I am one who believes that neither party wins with government shut down or certainly government default so I lean toward being a little more optimistic that the latter will be avoided,” said former Senate Budget Committee Republican staff director Bill Hoagland, who’s now at the Bipartisan Policy Center. “But this is really an uncertain time.”</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Biden Economic Agenda Confronts Tripwires Everywhere in Congress</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBiden Economic Agenda Confronts Tripwires Everywhere in Congress\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-13 09:02 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-08-12/biden-economic-agenda-confronts-tripwires-everywhere-in-congress?srnd=economics-vp><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Debt ceiling, funding deadline complicates path after break\nDemocrats aim for early fall completion, but obstacles await\n\nThe central pieces of President Joe Biden’s $4.1 trillion economic agenda are ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-08-12/biden-economic-agenda-confronts-tripwires-everywhere-in-congress?srnd=economics-vp\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.bloomberg.com/news/articles/2021-08-12/biden-economic-agenda-confronts-tripwires-everywhere-in-congress?srnd=economics-vp","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1154636497","content_text":"Debt ceiling, funding deadline complicates path after break\nDemocrats aim for early fall completion, but obstacles await\n\nThe central pieces of President Joe Biden’s $4.1 trillion economic agenda are now moving through Congress on a precarious two-track path that’s further complicated by a September showdown over the debt ceiling.\nFunding for the government will expire and the Treasury will approach the limit of its borrowing authority just as congressional Democrats try to make the administration’s massive infrastructure and social spending plans a reality.\nThe convergence will test the limits of how well House Speaker Nancy Pelosi and Senator Majority Leader Chuck Schumer can manage their narrow -- and often fractious -- majorities and Biden’s ability to bargain with dissenters.\nThe first part of Biden’s plan, infrastructure legislation with $550 billion in new spending, passed the Senate on a bipartisan basis. But the framework for a much larger plan -- a $3.5 trillion budget resolution opening the way to expansive spending on social programs paid for in part by taxes on the wealthy and corporations -- squeaked through on a straight party-line vote.\nHere’s what’s ahead for a process that could last through year-end:\nHouse Vote\nPelosi is briefly interrupting the chamber’s summer recess by calling lawmakers back to Washington on Aug. 23 to vote on the Senate’s budget resolution.\nShe needs near-unanimous Democratic support to adopt it against anticipated unified GOP opposition. The resolution is just an outline setting the parameters for an eventual budget bill and instructions for committees to draw up legislative text. It doesn’t require the president’s signature.\nFor now, the infrastructure bill is on hold. In a bow to demands by House progressives, Pelosi has vowed to wait until the Senate finishes the budget package to assure it addresses priorities on social programs and climate change. House Democrats may also want changes to the carefully negotiated infrastructure legislation.\nCommittee Work\nBoth chambers will then move to write precise policies and other language for the massive budget package, with the House likely to go first, predicts Zach Moller, a former Democratic Senate staffer who now works for Third Way, a centrist policy-research organization.\nHouse Democrats, ranging from top Pelosi lieutenants and powerful committee chairs to upstart progressives, are already signaling various changes they want to see in a final version of the Senate’s reconciliation package.\nThe Senate-passed resolution sets a nonbinding Sept. 15 deadline for committees in both chambers to submit proposals to their respective budget panels.\nThe Senate Finance Committee has jurisdiction over the heart of the package, including the tax hikes on the wealthy and corporations. Other committees can increase the deficit by about $1.75 trillion combined over a decade -- meaningup tohalf of Biden’s plan could be debt-financed.\nThere is no firm deadline on passage of the economic agenda, but Democrats keen on keeping their congressional majorities in the November 2022 midterm elections want the packages enacted this fall. That would allow voters time tofeelthe legislation’s effects and provide for the extension of popular pandemic-era benefits like the expanded child tax credit, which would otherwise end in December.\nFunding Showdown\nBy Sept. 30, lawmakers must reach bipartisan deals on unfinished regular government spending bills or on a stopgap bill to keep agencies running that would maintain current spending levels through at least October or early November.\nSuch a measure could carry language temporarily suspending the debt limit. But doing so could trigger a government shutdown. Republicans say Democrats must go it alone on the debt ceiling and want them to revise the budget resolution to allow them to pass a hike with a simple majority.\nSenate Democrats, however, insist for now on using the regular legislative process, which would require at least 10 Republicans to join them. Prospects for a bitter battle this fall have alreadystarted to impact short-term debt markets.\nHazards Ahead\nObstacles abound in the coming months. For one, House Democrats can afford just three defectors in a party-line vote. In the evenly divided Senate, unity is the only option.\nEven the House’s vote this month on the budget framework is no slam dunk. Party moderates, who want an immediate vote on the infrastructure package, could withhold their backing, stalling the measure.\nIn the Senate, not all Democrats are on board with the $3.5 trillion package, even though they all voted for the framework. Some, like Kyrsten Sinema of Arizona and Joe Manchin of West Virginia, say they’re uncomfortable with the price tag or the size of the tax hikes Biden has proposed to help pay for it.\nManchin has also said he disagrees with Democrats who want to target fossil fuels -- setting up tension for a key piece of the legislation.\nSchumer asserted Wednesday Democrats would ultimately unite, but he acknowledged it wouldn’t be easy.\nRepublicans will have ample opportunity to split Democrats and make their case that more taxes and spending will increase inflation and hurt the economy. Under special Senate rules they can force nearly unlimited amendments trying to strike individual provisions, potentially peeling off some Democrats in politically fraught votes.\nProcedural Pitfalls\nThe package will still have to clear a major procedural hurdle scrubbing it of anything deemed incidental to the federal budget.\nBiden’s $1.9 trillion Covid-19 relief package was shorn of a proposal for a $15-an-hour minimum wage via that process. Potential challenges in the $3.5 trillion plan include providing a path to citizenship for millions of immigrants.\nAll of this comes with long-term implications. In the short term, any misstep -- particularly on government spending and the debt ceiling -- could have large-scale reverberations in the market and the broader economy.\n“I am one who believes that neither party wins with government shut down or certainly government default so I lean toward being a little more optimistic that the latter will be avoided,” said former Senate Budget Committee Republican staff director Bill Hoagland, who’s now at the Bipartisan Policy Center. “But this is really an uncertain time.”","news_type":1},"isVote":1,"tweetType":1,"viewCount":227,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":894826950,"gmtCreate":1628817475070,"gmtModify":1631885122752,"author":{"id":"3573383772698946","authorId":"3573383772698946","name":"pralala","avatar":"https://static.tigerbbs.com/a6018cc8ea8414980b33b04dfc9fc497","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573383772698946","authorIdStr":"3573383772698946"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/CLOV\">$Clover Health Corp(CLOV)$</a>We saw 10 but it was only for a short period.. wait, what’s 10 when this has to be 100","listText":"<a href=\"https://laohu8.com/S/CLOV\">$Clover Health Corp(CLOV)$</a>We saw 10 but it was only for a short period.. wait, what’s 10 when this has to be 100","text":"$Clover Health Corp(CLOV)$We saw 10 but it was only for a short period.. wait, what’s 10 when this has to be 100","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/894826950","isVote":1,"tweetType":1,"viewCount":407,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":895849099,"gmtCreate":1628735201311,"gmtModify":1631888839574,"author":{"id":"3573383772698946","authorId":"3573383772698946","name":"pralala","avatar":"https://static.tigerbbs.com/a6018cc8ea8414980b33b04dfc9fc497","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573383772698946","authorIdStr":"3573383772698946"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/BYSI\">$Beyondspring Inc(BYSI)$</a>Why is a good company having such trouble?","listText":"<a href=\"https://laohu8.com/S/BYSI\">$Beyondspring Inc(BYSI)$</a>Why is a good company having such trouble?","text":"$Beyondspring Inc(BYSI)$Why is a good company having such trouble?","images":[{"img":"https://static.tigerbbs.com/44286c78b46afb7b49a8b8507e66789a","width":"828","height":"1590"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/895849099","isVote":1,"tweetType":1,"viewCount":48,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":892583824,"gmtCreate":1628672347568,"gmtModify":1631888839575,"author":{"id":"3573383772698946","authorId":"3573383772698946","name":"pralala","avatar":"https://static.tigerbbs.com/a6018cc8ea8414980b33b04dfc9fc497","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573383772698946","authorIdStr":"3573383772698946"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/BYSI\">$Beyondspring Inc(BYSI)$</a>Why doesn’t it move much in Premarket","listText":"<a href=\"https://laohu8.com/S/BYSI\">$Beyondspring Inc(BYSI)$</a>Why doesn’t it move much in Premarket","text":"$Beyondspring Inc(BYSI)$Why doesn’t it move much in Premarket","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/892583824","isVote":1,"tweetType":1,"viewCount":183,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":893191527,"gmtCreate":1628243365369,"gmtModify":1631885123408,"author":{"id":"3573383772698946","authorId":"3573383772698946","name":"pralala","avatar":"https://static.tigerbbs.com/a6018cc8ea8414980b33b04dfc9fc497","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573383772698946","authorIdStr":"3573383772698946"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/CLOV\">$Clover Health Corp(CLOV)$</a>It’s been quite long since we saw $CLOV green pre, during and post-market 🍀&nbsp;","listText":"<a href=\"https://laohu8.com/S/CLOV\">$Clover Health Corp(CLOV)$</a>It’s been quite long since we saw $CLOV green pre, during and post-market 🍀&nbsp;","text":"$Clover Health Corp(CLOV)$It’s been quite long since we saw $CLOV green pre, during and post-market 🍀","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/893191527","isVote":1,"tweetType":1,"viewCount":128,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":185504542,"gmtCreate":1623658238486,"gmtModify":1634030553544,"author":{"id":"3573383772698946","authorId":"3573383772698946","name":"pralala","avatar":"https://static.tigerbbs.com/a6018cc8ea8414980b33b04dfc9fc497","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573383772698946","authorIdStr":"3573383772698946"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/AMC\">$AMC Entertainment(AMC)$</a>No one said it was going to be easy 💎🙌🏽","listText":"<a href=\"https://laohu8.com/S/AMC\">$AMC Entertainment(AMC)$</a>No one said it was going to be easy 💎🙌🏽","text":"$AMC Entertainment(AMC)$No one said it was going to be easy 💎🙌🏽","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":15,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/185504542","isVote":1,"tweetType":1,"viewCount":722,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":183697709,"gmtCreate":1623327064901,"gmtModify":1634034565236,"author":{"id":"3573383772698946","authorId":"3573383772698946","name":"pralala","avatar":"https://static.tigerbbs.com/a6018cc8ea8414980b33b04dfc9fc497","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573383772698946","authorIdStr":"3573383772698946"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/CLOV\">$Clover Health Corp(CLOV)$</a>Those who don’t like this stock, wtf are you lurking around here for?!","listText":"<a href=\"https://laohu8.com/S/CLOV\">$Clover Health Corp(CLOV)$</a>Those who don’t like this stock, wtf are you lurking around here for?!","text":"$Clover Health Corp(CLOV)$Those who don’t like this stock, wtf are you lurking around here for?!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":7,"repostSize":0,"link":"https://laohu8.com/post/183697709","isVote":1,"tweetType":1,"viewCount":2873,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":803730113,"gmtCreate":1627462342032,"gmtModify":1631893751582,"author":{"id":"3573383772698946","authorId":"3573383772698946","name":"pralala","avatar":"https://static.tigerbbs.com/a6018cc8ea8414980b33b04dfc9fc497","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573383772698946","authorIdStr":"3573383772698946"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/AMC\">$AMC Entertainment(AMC)$</a>$50 tonight possible?","listText":"<a href=\"https://laohu8.com/S/AMC\">$AMC Entertainment(AMC)$</a>$50 tonight possible?","text":"$AMC Entertainment(AMC)$$50 tonight possible?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":17,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/803730113","isVote":1,"tweetType":1,"viewCount":765,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":807680609,"gmtCreate":1628034722201,"gmtModify":1631891282884,"author":{"id":"3573383772698946","authorId":"3573383772698946","name":"pralala","avatar":"https://static.tigerbbs.com/a6018cc8ea8414980b33b04dfc9fc497","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573383772698946","authorIdStr":"3573383772698946"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/AMC\">$AMC Entertainment(AMC)$</a>Together fam 💎🙌🏽","listText":"<a href=\"https://laohu8.com/S/AMC\">$AMC Entertainment(AMC)$</a>Together fam 💎🙌🏽","text":"$AMC Entertainment(AMC)$Together fam 💎🙌🏽","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":12,"commentSize":1,"repostSize":1,"link":"https://laohu8.com/post/807680609","isVote":1,"tweetType":1,"viewCount":352,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":157030893,"gmtCreate":1625551662612,"gmtModify":1631885126628,"author":{"id":"3573383772698946","authorId":"3573383772698946","name":"pralala","avatar":"https://static.tigerbbs.com/a6018cc8ea8414980b33b04dfc9fc497","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573383772698946","authorIdStr":"3573383772698946"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/CLOV\">$Clover Health Corp(CLOV)$</a>Cmon fam HODL💎🙌🏽","listText":"<a href=\"https://laohu8.com/S/CLOV\">$Clover Health Corp(CLOV)$</a>Cmon fam HODL💎🙌🏽","text":"$Clover Health Corp(CLOV)$Cmon fam HODL💎🙌🏽","images":[{"img":"https://static.tigerbbs.com/ba3c1c36a4e143697525d65d1f54c508","width":"828","height":"1434"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":6,"repostSize":0,"link":"https://laohu8.com/post/157030893","isVote":1,"tweetType":1,"viewCount":697,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3554171307804467","authorId":"3554171307804467","name":"不轻易买股票","avatar":"https://static.tigerbbs.com/9591045ed55f6fad3186a4cd347989e0","crmLevel":1,"crmLevelSwitch":0,"idStr":"3554171307804467","authorIdStr":"3554171307804467"},"content":"你这不平均下来？","text":"你这不平均下来？","html":"你这不平均下来？"}],"imageCount":1,"langContent":"EN","totalScore":0},{"id":807063375,"gmtCreate":1627989347997,"gmtModify":1631885123509,"author":{"id":"3573383772698946","authorId":"3573383772698946","name":"pralala","avatar":"https://static.tigerbbs.com/a6018cc8ea8414980b33b04dfc9fc497","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573383772698946","authorIdStr":"3573383772698946"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/CLOV\">$Clover Health Corp(CLOV)$</a>Guys be patient. Stick&nbsp;together gain together 🙏🏽","listText":"<a href=\"https://laohu8.com/S/CLOV\">$Clover Health Corp(CLOV)$</a>Guys be patient. Stick&nbsp;together gain together 🙏🏽","text":"$Clover Health Corp(CLOV)$Guys be patient. Stick together gain together 🙏🏽","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":13,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/807063375","isVote":1,"tweetType":1,"viewCount":365,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":168885613,"gmtCreate":1623971564132,"gmtModify":1631885193380,"author":{"id":"3573383772698946","authorId":"3573383772698946","name":"pralala","avatar":"https://static.tigerbbs.com/a6018cc8ea8414980b33b04dfc9fc497","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573383772698946","authorIdStr":"3573383772698946"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ZOM\">$Zomedica Pharmaceuticals Corp.(ZOM)$</a>😸","listText":"<a href=\"https://laohu8.com/S/ZOM\">$Zomedica Pharmaceuticals Corp.(ZOM)$</a>😸","text":"$Zomedica Pharmaceuticals Corp.(ZOM)$😸","images":[{"img":"https://static.tigerbbs.com/6c6f9cf6f8ae905f53afad484a84ce82","width":"828","height":"614"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":2,"repostSize":1,"link":"https://laohu8.com/post/168885613","isVote":1,"tweetType":1,"viewCount":591,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":119420630,"gmtCreate":1622559699720,"gmtModify":1634100459519,"author":{"id":"3573383772698946","authorId":"3573383772698946","name":"pralala","avatar":"https://static.tigerbbs.com/a6018cc8ea8414980b33b04dfc9fc497","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573383772698946","authorIdStr":"3573383772698946"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/AMC\">$AMC Entertainment(AMC)$</a>Stop the negativity! Wish ppl good luck! 💎🙌🏽🚀","listText":"<a href=\"https://laohu8.com/S/AMC\">$AMC Entertainment(AMC)$</a>Stop the negativity! Wish ppl good luck! 💎🙌🏽🚀","text":"$AMC Entertainment(AMC)$Stop the negativity! Wish ppl good luck! 💎🙌🏽🚀","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":13,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/119420630","isVote":1,"tweetType":1,"viewCount":449,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":150972645,"gmtCreate":1624885314187,"gmtModify":1631885127872,"author":{"id":"3573383772698946","authorId":"3573383772698946","name":"pralala","avatar":"https://static.tigerbbs.com/a6018cc8ea8414980b33b04dfc9fc497","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573383772698946","authorIdStr":"3573383772698946"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/CLOV\">$Clover Health Corp(CLOV)$</a>0 shares left to borrow.. hang on tight.. tonight will be painful 💎🙌🏽","listText":"<a href=\"https://laohu8.com/S/CLOV\">$Clover Health Corp(CLOV)$</a>0 shares left to borrow.. hang on tight.. tonight will be painful 💎🙌🏽","text":"$Clover Health Corp(CLOV)$0 shares left to borrow.. hang on tight.. tonight will be painful 💎🙌🏽","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":14,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/150972645","isVote":1,"tweetType":1,"viewCount":102,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":115604851,"gmtCreate":1622981034373,"gmtModify":1634096428905,"author":{"id":"3573383772698946","authorId":"3573383772698946","name":"pralala","avatar":"https://static.tigerbbs.com/a6018cc8ea8414980b33b04dfc9fc497","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573383772698946","authorIdStr":"3573383772698946"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/AMC\">$AMC Entertainment(AMC)$</a>💎🙌🏽&nbsp;🦍&nbsp;","listText":"<a href=\"https://laohu8.com/S/AMC\">$AMC Entertainment(AMC)$</a>💎🙌🏽&nbsp;🦍&nbsp;","text":"$AMC Entertainment(AMC)$💎🙌🏽 🦍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":0,"repostSize":1,"link":"https://laohu8.com/post/115604851","isVote":1,"tweetType":1,"viewCount":129,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":804523584,"gmtCreate":1627965893648,"gmtModify":1631885123509,"author":{"id":"3573383772698946","authorId":"3573383772698946","name":"pralala","avatar":"https://static.tigerbbs.com/a6018cc8ea8414980b33b04dfc9fc497","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573383772698946","authorIdStr":"3573383772698946"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/CLOV\">$Clover Health Corp(CLOV)$</a>Come closer 🙏🏽","listText":"<a href=\"https://laohu8.com/S/CLOV\">$Clover Health Corp(CLOV)$</a>Come closer 🙏🏽","text":"$Clover Health Corp(CLOV)$Come closer 🙏🏽","images":[{"img":"https://static.tigerbbs.com/1fa45b5eac13c600f8add0083daf9752","width":"828","height":"1590"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":1,"link":"https://laohu8.com/post/804523584","isVote":1,"tweetType":1,"viewCount":137,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":156004559,"gmtCreate":1625184729071,"gmtModify":1631885127324,"author":{"id":"3573383772698946","authorId":"3573383772698946","name":"pralala","avatar":"https://static.tigerbbs.com/a6018cc8ea8414980b33b04dfc9fc497","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573383772698946","authorIdStr":"3573383772698946"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/CLOV\">$Clover Health Corp(CLOV)$</a>💎🙌🏽","listText":"<a href=\"https://laohu8.com/S/CLOV\">$Clover Health Corp(CLOV)$</a>💎🙌🏽","text":"$Clover Health Corp(CLOV)$💎🙌🏽","images":[{"img":"https://static.tigerbbs.com/feee3071baa0c95a816e88c5d573ac70","width":"828","height":"1590"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/156004559","isVote":1,"tweetType":1,"viewCount":307,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":189610762,"gmtCreate":1623255197656,"gmtModify":1634035254054,"author":{"id":"3573383772698946","authorId":"3573383772698946","name":"pralala","avatar":"https://static.tigerbbs.com/a6018cc8ea8414980b33b04dfc9fc497","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573383772698946","authorIdStr":"3573383772698946"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/CLOV\">$Clover Health Corp(CLOV)$</a>💎🙌🏽 Diamonds are made under pressure. remember that!","listText":"<a href=\"https://laohu8.com/S/CLOV\">$Clover Health Corp(CLOV)$</a>💎🙌🏽 Diamonds are made under pressure. remember that!","text":"$Clover Health Corp(CLOV)$💎🙌🏽 Diamonds are made under pressure. remember that!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":10,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/189610762","isVote":1,"tweetType":1,"viewCount":59,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":115659477,"gmtCreate":1622989441599,"gmtModify":1634096381954,"author":{"id":"3573383772698946","authorId":"3573383772698946","name":"pralala","avatar":"https://static.tigerbbs.com/a6018cc8ea8414980b33b04dfc9fc497","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573383772698946","authorIdStr":"3573383772698946"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/AMC\">$AMC Entertainment(AMC)$</a>💎🙌🏽","listText":"<a href=\"https://laohu8.com/S/AMC\">$AMC Entertainment(AMC)$</a>💎🙌🏽","text":"$AMC Entertainment(AMC)$💎🙌🏽","images":[{"img":"https://static.tigerbbs.com/e0c34e8f918d674ba4bf3e7e9cf7d632","width":"1075","height":"806"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":10,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/115659477","isVote":1,"tweetType":1,"viewCount":401,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":804402765,"gmtCreate":1627969158557,"gmtModify":1631891282889,"author":{"id":"3573383772698946","authorId":"3573383772698946","name":"pralala","avatar":"https://static.tigerbbs.com/a6018cc8ea8414980b33b04dfc9fc497","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573383772698946","authorIdStr":"3573383772698946"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/AMC\">$AMC Entertainment(AMC)$</a>Patience is a virtue 💎🙌🏽","listText":"<a href=\"https://laohu8.com/S/AMC\">$AMC Entertainment(AMC)$</a>Patience is a virtue 💎🙌🏽","text":"$AMC Entertainment(AMC)$Patience is a virtue 💎🙌🏽","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":11,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/804402765","isVote":1,"tweetType":1,"viewCount":5,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":105233724,"gmtCreate":1620304851468,"gmtModify":1631889275811,"author":{"id":"3573383772698946","authorId":"3573383772698946","name":"pralala","avatar":"https://static.tigerbbs.com/a6018cc8ea8414980b33b04dfc9fc497","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573383772698946","authorIdStr":"3573383772698946"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/HOFV\">$Hall of Fame Resort &amp; Entertainment(HOFV)$</a>💎🙌🏽","listText":"<a href=\"https://laohu8.com/S/HOFV\">$Hall of Fame Resort &amp; Entertainment(HOFV)$</a>💎🙌🏽","text":"$Hall of Fame Resort & Entertainment(HOFV)$💎🙌🏽","images":[{"img":"https://static.tigerbbs.com/08bb7d67275f1992084d213f3a69bad6","width":"828","height":"1556"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/105233724","isVote":1,"tweetType":1,"viewCount":899,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":863016492,"gmtCreate":1632330976616,"gmtModify":1632801160394,"author":{"id":"3573383772698946","authorId":"3573383772698946","name":"pralala","avatar":"https://static.tigerbbs.com/a6018cc8ea8414980b33b04dfc9fc497","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573383772698946","authorIdStr":"3573383772698946"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/CLOV\">$Clover Health Corp(CLOV)$</a>🙏🏽","listText":"<a href=\"https://laohu8.com/S/CLOV\">$Clover Health Corp(CLOV)$</a>🙏🏽","text":"$Clover Health Corp(CLOV)$🙏🏽","images":[{"img":"https://static.tigerbbs.com/47e7305d55ee3423718c865071fc4788","width":"828","height":"1792"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/863016492","isVote":1,"tweetType":1,"viewCount":288,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":806591544,"gmtCreate":1627663734488,"gmtModify":1631885123577,"author":{"id":"3573383772698946","authorId":"3573383772698946","name":"pralala","avatar":"https://static.tigerbbs.com/a6018cc8ea8414980b33b04dfc9fc497","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573383772698946","authorIdStr":"3573383772698946"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/CLOV\">$Clover Health Corp(CLOV)$</a>Waiting for Christmas 🎄&nbsp;","listText":"<a href=\"https://laohu8.com/S/CLOV\">$Clover Health Corp(CLOV)$</a>Waiting for Christmas 🎄&nbsp;","text":"$Clover Health Corp(CLOV)$Waiting for Christmas 🎄","images":[{"img":"https://static.tigerbbs.com/f90d25de7360676b6b9a0dc2eeea7e1a","width":"828","height":"1434"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/806591544","isVote":1,"tweetType":1,"viewCount":78,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":188398507,"gmtCreate":1623420949609,"gmtModify":1631885517457,"author":{"id":"3573383772698946","authorId":"3573383772698946","name":"pralala","avatar":"https://static.tigerbbs.com/a6018cc8ea8414980b33b04dfc9fc497","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573383772698946","authorIdStr":"3573383772698946"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/CLOV\">$Clover Health Corp(CLOV)$</a>Don’t listen to the naysayers! Why would they wanna come advise us? You think they care about us?","listText":"<a href=\"https://laohu8.com/S/CLOV\">$Clover Health Corp(CLOV)$</a>Don’t listen to the naysayers! Why would they wanna come advise us? You think they care about us?","text":"$Clover Health Corp(CLOV)$Don’t listen to the naysayers! Why would they wanna come advise us? You think they care about us?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/188398507","isVote":1,"tweetType":1,"viewCount":503,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":114903005,"gmtCreate":1623039881007,"gmtModify":1634095952067,"author":{"id":"3573383772698946","authorId":"3573383772698946","name":"pralala","avatar":"https://static.tigerbbs.com/a6018cc8ea8414980b33b04dfc9fc497","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573383772698946","authorIdStr":"3573383772698946"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/AMC\">$AMC Entertainment(AMC)$</a>Everyone gotto know that this is not a fundamental play. It’s a collective effort against the unfairness done by the HF all these while.&nbsp;All the manipulation, naked shortsetc. We apes are together in this fight! 💎🙌🏽🦍","listText":"<a href=\"https://laohu8.com/S/AMC\">$AMC Entertainment(AMC)$</a>Everyone gotto know that this is not a fundamental play. It’s a collective effort against the unfairness done by the HF all these while.&nbsp;All the manipulation, naked shortsetc. We apes are together in this fight! 💎🙌🏽🦍","text":"$AMC Entertainment(AMC)$Everyone gotto know that this is not a fundamental play. It’s a collective effort against the unfairness done by the HF all these while. All the manipulation, naked shortsetc. We apes are together in this fight! 💎🙌🏽🦍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/114903005","isVote":1,"tweetType":1,"viewCount":252,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}